Enabling Innovation in Medicine and Healthcare


Is this the future of cardiovascular devices?

October 4, 2016

This  is amazing technology that allows the body to regenerate functional tissues.

Regenerative Medicine for Skin Burns

August 23, 2016

Burn treatment is a major area of application for regenerative medicine.  As evidenced by the companies discussed in this article, not only are stem cells proving to be effective in generating skin re-growth, but the technologies to make this treatment clinical viable continue to improve.

TAVR isn't perfect ... yet

May 24, 2016

This is an interesting study published by the very reputable group at St. Paul's Hospital in Vancouver.   There has been increasing acceptance of TAVR as the FDA continues to approve its use for lower risk patient groups.  However, this longer term study found early degeneration in half of the TAVR's.  Some of this was attributable to intravalvular regurgitation, which is being addressed in newer versions of the valves.  However, a third of these were due to valvular stenosis. 

With the excitement around minimally invasive valve procedures and the introduction of the new mitral valves, stenosis seems to be a bit on the back burner.  One of Zymetrix' clients, Dr. Kishan Narine of the Libin Cardiovascular Institute, has recently completed a prototype of an aortic valve using a proprietary material and leaflet design that shows improved hemodynamics and reduced leaflet stresses in early testing.  The next step will be preclinical studies where it is expected to show reduced calcification.

Albertans win first Governor General's Innovation Awards

May 24, 2016

Alberta entrepreneurs were recognized for their success as they were amongst the recipients of the first Governor General's Innovation Awards.  Congratulations to Breanne Everett and her team at Orpyx and to Robert Burrell at the University of Alberta. 

Ammolite Biomodels wins TENET I2C competition

April 6, 2016

Congratulations to Aubrey Blair-Pattison and Ammolite Biomodels for winning the inaugural $100,000 TENET I2C competition for translational medical technologies.  A realistic and cost-effective training option, Ammolite BioModels’ Tactile Bones aim to reduce the cost, time and risks of surgeries by improving training outside the operating room.  Ammolite's technology was developed within the Schulich School of Engineering at the University of Calgary within the Zymetrix lab space.

TAVR continues to expand

April 4, 2016

Trials are supporting expanded use of TAVR, and the companies are certainly liking it.

Calgary based Surface Medical increases market reach

March 2, 2016

One of Zymetrix' regular testing clients, Surface Medical, has inked a distribution partnership to get their CleanPatch product into the US market.